Matsuo H - Search Results

1

Real-world application of plasmapheresis for neurological disease: Results from the Japan-Plasmapheresis Outcome and Practice Patterns Study.

Lin Y, Oji S, Miyamoto K, Narita T, Kameyama M, Matsuo H. Lin Y, et al. Among authors: matsuo h. Ther Apher Dial. 2023 Feb;27(1):123-135. doi: 10.1111/1744-9987.13906. Epub 2022 Jul 17. Ther Apher Dial. 2023. PMID: 35765859 Free PMC article.

2

Myasthenic crisis with delayed recovery after plasmapheresis.

Matsuo H, Goto H, Ohtsuru I, Izumoto H, Fukudome T, Fujishita S, Shibuya N. Matsuo H, et al. Ther Apher. 1999 Nov;3(4):326-8. doi: 10.1046/j.1526-0968.1999.00205.x. Ther Apher. 1999. PMID: 10608729

3

Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes.

Goto H, Matsuo H, Nakane S, Izumoto H, Fukudome T, Kambara C, Shibuya N. Goto H, et al. Among authors: matsuo h. Ther Apher. 2001 Dec;5(6):494-6. doi: 10.1046/j.1526-0968.2001.00386.x. Ther Apher. 2001. PMID: 11800088

4

Miller Fisher syndrome and plasmapheresis.

Kambara C, Matsuo H, Fukudome T, Goto H, Shibuya N. Kambara C, et al. Among authors: matsuo h. Ther Apher. 2002 Dec;6(6):450-3. doi: 10.1046/j.1526-0968.2002.00466.x. Ther Apher. 2002. PMID: 12460409

5

[Left-sided metamorphopsia of the face and simple objects caused by an infarction at the right side of the splenium of the corpus callosum].

Nagaishi A, Narita T, Gondo Y, Nakane S, Fukudome T, Matsuo H. Nagaishi A, et al. Among authors: matsuo h. Rinsho Shinkeigaku. 2015;55(7):465-71. doi: 10.5692/clinicalneurol.cn-000666. Epub 2015 May 22. Rinsho Shinkeigaku. 2015. PMID: 26004257 Review. Japanese.

6

Autoantibodies in Japanese patients with ocular myasthenia gravis.

Nagaishi A, Narita T, Woodhall M, Jacobson L, Waters P, Irani SR, Vincent A, Matsuo H. Nagaishi A, et al. Among authors: matsuo h. Muscle Nerve. 2021 Feb;63(2):262-267. doi: 10.1002/mus.27103. Epub 2020 Nov 12. Muscle Nerve. 2021. PMID: 33094484 Free PMC article.

7

Very late onset neuromyelitis optica spectrum disorders.

Nakahara K, Nakane S, Nagaishi A, Narita T, Matsuo H, Ando Y. Nakahara K, et al. Among authors: matsuo h. Eur J Neurol. 2021 Aug;28(8):2574-2581. doi: 10.1111/ene.14901. Epub 2021 May 25. Eur J Neurol. 2021. PMID: 33960076

8

Treatment of experimental allergic encephalomyelitis by selective removal of CD4+ T cells.

Matsuo H, Ichinose K, Ohtsuru I, Fujishita S, Onodera H, Suematsu J, Yoshida M, Yamawaki N, Shibuya N. Matsuo H, et al. Ther Apher. 1997 May;1(2):165-8. doi: 10.1111/j.1744-9987.1997.tb00034.x. Ther Apher. 1997. PMID: 10225764

9

Development of a device for selective removal of CD4+ T cells.

Onodera H, Ninomiya K, Yoshida M, Matsuo H, Shibuya N. Onodera H, et al. Among authors: matsuo h. Ther Apher Dial. 2003 Jun;7(3):329-33. doi: 10.1046/j.1526-0968.2003.00050.x. Ther Apher Dial. 2003. PMID: 12924608

10

Selective adsorption of human CD4 T cells.

Matsuo H, Goto H, Kambara C, Fukudome T, Mizota T, Onodera H, Yoshida M, Shibuya N. Matsuo H, et al. Ther Apher Dial. 2004 Jun;8(3):194-6. doi: 10.1111/j.1526-0968.2004.00146.x. Ther Apher Dial. 2004. PMID: 15154870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,265 results

Search Page